FRTX — Fresh Tracks Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapTurnaround

Annual balance sheet for Fresh Tracks Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11.7	30.1	26.9	8.68	10.9
Net Total Accounts Receivable
Net Total Receivables	—	—	—	—	0.045
Prepaid Expenses
Total Other Current Assets
Total Current Assets	18	33.5	29.6	10.1	11.6
Net Property, Plant And Equipment	0.175	0.104	0.117	0.124	0.034
Net Intangible Assets
Long Term Notes Receivable
Total Assets	18.1	33.6	29.7	10.3	11.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	10.5	6.35	4.81	3.08	1.66
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.6	6.5	4.81	3.08	1.66
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	7.57	27.1	24.9	7.19	9.93
Total Liabilities & Shareholders' Equity	18.1	33.6	29.7	10.3	11.6
Total Common Shares Outstanding